MindFuel Blog

Fantastic news from our friends across the ditch: From July, authorized Australian psychiatrists will be able to prescribe the MDMA and Psilocybin (the active ingredient in magic mushrooms) for post-traumatic stress disorder (PTSD) and severe depression.

Less than two years ago, the amazing scientists at the Johns Hopkins Psychedelic Research Unit began studying the effects of Psilocybin, one of the main psychoactive substances found in magic mushrooms. The preliminary results are out: 83% of their participants showed a clinically significant reduction in depression symptoms 53% met criteria for remission. Stay tuned for the results of their...